Effect of Dexmedetomidine Versus Dexamethasone as Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block on Postoperative Analgesia in Myasthenic Patients Undergoing Thoracoscopic Thymectomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAin Shams University

About this trial

This current comparative study involved 54 patients undergoing thoracoscopic thymectomy who were distributed randomly into three equal groups to receive ultrasound (US)-guided ESPB using 20 ml bupivacaine 0.25% (group B) , 20 ml bupivacaine 0.25% with 8 mg dexamethasone (group BS), 20 ml bupivacaine 0.25% with dexmedetomidine 1mcg/kg (group BM). The time till the first postoperative rescue analgesic requested was the primary outcome. The secondary outcomes included the postoperative pain scores and analgesic consumption.

Eligibility criteria

Qualifiers

myasthenic patients

American Society of Anesthesiologists (ASA) physical grade of 2-3)

who underwent video assisted thoracoscopic thymectomy

Disqualifiers

Refused participation in the study,

known allergy for this study drugs ,

Contraindication to the ESPB as infection at block site & marked chest cage deformity,

significant bleeding disorders ,

Trial design

Treatments tested in this trial

  • Erector Spinae Plane Block
  • Erector Spinae Plane Block
  • Erector Spinae Plane Block

Treatment groups

60 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators